Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Large Increase in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 4,409 shares, a growth of 64.3% from the June 30th total of 2,684 shares. Based on an average daily volume of 5,551 shares, the short-interest ratio is currently 0.8 days.

Cardio Diagnostics Price Performance

NASDAQ:CDIOW traded down $0.00 on Friday, reaching $0.01. The stock had a trading volume of 2,500 shares, compared to its average volume of 46,002. Cardio Diagnostics has a 1-year low of $0.01 and a 1-year high of $0.07. The stock has a fifty day moving average price of $0.02 and a 200-day moving average price of $0.02.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.